US 12,478,798 B2
Jaundice diagnosis and treatment system and computer-readable storage medium
Yuanyuan Cui, Beijing (CN)
Assigned to BEIJING BOE TECHNOLOGY DEVELOPMENT CO., LTD., Beijing (CN)
Appl. No. 17/782,998
Filed by BOE Technology Group Co., Ltd., Beijing (CN)
PCT Filed May 13, 2021, PCT No. PCT/CN2021/093656
§ 371(c)(1), (2) Date Jun. 7, 2022,
PCT Pub. No. WO2021/244253, PCT Pub. Date Dec. 9, 2021.
Claims priority of application No. 202010498707.5 (CN), filed on Jun. 4, 2020.
Prior Publication US 2023/0001228 A1, Jan. 5, 2023
Int. Cl. A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61N 5/06 (2006.01)
CPC A61N 5/0621 (2013.01) [A61B 5/14546 (2013.01); A61B 5/7275 (2013.01); A61B 2503/045 (2013.01)] 13 Claims
OG exemplary drawing
 
10. A computer implemented method for diagnosing and treating jaundice, comprising:
detecting a bilirubin concentration of a newborn;
generating detection data according to the detected bilirubin concentration;
evaluating a risk level of pathological jaundice according to the detection data; and
displaying the detection data and/or the risk level of pathological jaundice,
wherein the computer-implemented method further comprises:
receiving a phototherapy parameter that has been applied to the newborn;
calculating a recommended phototherapy parameter according to the detection data and the applied phototherapy parameter;
displaying the recommended phototherapy parameter; and
performing illumination according to the recommended phototherapy parameter,
wherein the evaluating the risk level of pathological jaundice according to the detection data comprises:
acquiring a birth time TB of the newborn, information on whether the newborn is full-term, and the detection data (Ti, Ci) of the newborn, where i is a natural number and is not greater than N, and is used to represent i-th bilirubin detection performed for the newborn; N represents N-th bilirubin detection latest performed for the newborn; Ti represents a time of the i-th bilirubin detection, and Ci represents a bilirubin concentration of the i-th bilirubin detection;
according to the detection data (TN, CN), determining whether an interval time TN,B between a detection time TN and the birth time TB is less than a first time threshold Tref1, and determining whether the bilirubin concentration CN is greater than a first concentration threshold Cref1, and generating first confirmation information when it is determined that the interval time TN,B is less than the first time threshold Tref1 and the bilirubin concentration CN is greater than the first concentration threshold Cref1;
determining whether the bilirubin concentration CN is greater than a second concentration threshold Cref2 which is greater than the first concentration threshold Cref1 according to the detection data (TN, CN), wherein, when the newborn is full-term, the second concentration threshold Cref2 is equal to a first reference concentration Cref21, and when the newborn is not full- term, the second concentration threshold Cref2 is equal to a second reference concentration Cref22, the first reference concentration Cref21 is less than the second reference concentration Cref22, and generating second confirmation information when it is determined that the bilirubin concentration CN is greater than the second concentration threshold Cref2;
calculating a first concentration change rate VN,N-1 according to the detection data (TN, CN) and the detection data (TN-1, CN-1) when N is greater than 1, where, VN,N-1=(CN-CN-1)/(TN-TN-1), and generating third confirmation information when the first concentration change rate VN,N-1 is greater than a reference rate threshold Vref1; and
determining that the risk level of pathological jaundice is a high risk according to the first confirmation information, the second confirmation information or the third confirmation information.